Study to Create a Registry to Collect the Findings and Outcomes of Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound (CE-EUS)

Overview

Información sobre este estudio

The purpose of this study is to describe the findings and outcomes of patient undergoing contrast-enhanced harmonic endoscopic ultrasound (CE-EUS) imaging. A registry will be created to monitor for possible procedure adverse events and to perform descriptive statistics for the patients who undergo this procedure.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Male and female patients aged 18 years to 99 years old.
  • Referred for endoscopic ultrasound. 
  • Based on clinical judgement of the advanced endoscopist, those who present with lesions where increased microvasculature and perfusion visualization with contrast-enhanced harmonic endoscopic ultrasound imaging would be of beneficial for lesion characterization.
  • Patients with esophageal, pancreatic, liver or gastric tumors, or adenopathy are anticipated to possibly benefit from improved lesion vascularity visualization with contrast-enhanced harmonic endoscopic ultrasound Imaging when compared with standard EUS/Doppler imaging.
  • Patients who cannot undergo contrast enhanced CT or MRI imaging due to renal failure or allergic reactions would benefit from this approach.
  • Clinical medical stability to undergo sedation for endoscopy.
  • Provide informed consent.

Exclusion Criteria:

  • Medical condition that precludes the patient from having an endoscopic procedure.
  • Patients who cannot provide adequate research authorization.
  • Patients with known allergies to ultrasound contrast agents.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Jacksonville, Fla.

Investigador principal de Mayo Clinic

Michael Wallace, M.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20450615

Mayo Clinic Footer